Randomized Controlled Open Label Trial on the Use of Favipiravir Combined with Inhaled Interferon beta-1b in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia

Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research